Pay in 4 interest-free payments of $7.02 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
Ozempic is contraindicated in patients with a family history of MTC or in patients with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
Both medications were originally placed on the FDA's drug shortage list in 2022, which had enabled compounding under the shortage pathway
Do not store in a bathroom
Combined Research Profile When investigated alongside complementary regenerative, antioxidant-support, or metabolic-support compounds, GHK-Cu is commonly researched for broader interaction with: Collagen-related signaling pathways Tissue-remodeling and regenerative mechanisms Skin-integrity and dermal-maintenance pathways Antioxidant-defense systems Oxidative-stress regulation pathways Recovery-focused physiological signaling Healthy-aging and physiological-resilience research Because GHK-Cu interacts with multiple regenerative and antioxidant-related pathways, it is commonly investigated as part of broader multi-pathway regenerative, skin-support, tissue-maintenance, and healthy-aging research protocols
The compound also showed strong results in models of acute lung injury, a serious condition that can occur during illnesses like sepsis or when patients require ventilators
